Last 24 quarters of trend data · Healthcare · Drug Manufacturers - General
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 19.08 | 8.46 | 2.72 | — | 4.38 | 4.32 | 11.28 | 8.88 | 3.47 | 6.90 | 6.03 | 1.69 | 18.87 | 5.48 | 8.52 | 16.63 | 6.57 | 9.17 | 6.42 | 9.64 | 6.45 |
| — | +95.8% | -75.9% | — | +26.3% | -37.4% | +87.2% | +424.7% | -81.6% | +26.0% | -29.3% | -89.8% | +187.1% | -40.3% | +32.7% | +72.5% | +1.8% | +103.7% | — | — | — | |
| P/S Ratio | 0.58 | 0.59 | 0.27 | 0.31 | 0.43 | 0.39 | 0.64 | 0.61 | 0.79 | 0.83 | 0.75 | 0.58 | 0.73 | 0.83 | 0.98 | 1.20 | 0.97 | 1.36 | 1.42 | 1.21 | 1.30 |
| — | +48.8% | -58.0% | -49.2% | -44.7% | -52.6% | -14.2% | +5.2% | +7.2% | +0.6% | -23.6% | -51.8% | -24.6% | -39.0% | -31.1% | -0.7% | -25.5% | +14.5% | — | — | — | |
| P/B Ratio | 4.76 | 3.64 | 1.74 | 2.48 | 3.07 | 3.44 | 7.17 | 8.21 | 10.08 | 37.17 | 101.19 | — | — | — | — | — | — | — | — | — | — |
| — | +5.9% | -75.7% | -69.8% | -69.5% | -90.8% | -92.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 6.71 | 14.08 | 2.09 | 4.86 | 4.67 | 3.48 | — | 3.76 | 19.11 | 4.46 | — | 2.93 | 5.40 | — | 25.10 | 8.83 | 14.63 | 20.31 | 37.12 | — | 6.79 |
| — | +304.9% | — | +29.3% | -75.6% | -22.0% | — | +28.4% | +253.9% | — | — | -66.8% | -63.1% | — | -32.4% | — | +115.5% | +1394.5% | — | — | — | |
| EV / EBITDA | 7.22 | 6.88 | 6.41 | 7.72 | 6.12 | 6.52 | 7.23 | 8.22 | 7.06 | 7.36 | 6.78 | 8.02 | 10.83 | 7.68 | 7.91 | 11.36 | 7.44 | 8.19 | 7.31 | 8.53 | 7.77 |
| — | +5.5% | -11.3% | -6.2% | -13.3% | -11.5% | +6.6% | +2.5% | -34.8% | -4.2% | -14.3% | -29.4% | +45.5% | -6.2% | +8.3% | +33.2% | -4.3% | +15.6% | — | — | — | |
| EV / EBIT | 9.21 | 9.52 | 6.97 | — | 7.37 | 7.51 | 13.66 | 11.55 | 9.73 | 9.09 | 8.85 | 12.81 | 14.83 | 8.89 | 9.73 | 13.40 | 9.08 | 11.01 | 8.03 | 9.80 | 8.68 |
| — | +26.8% | -49.0% | — | -24.2% | -17.4% | +54.3% | -9.9% | -34.4% | +2.2% | -9.0% | -4.4% | +63.2% | -19.2% | +21.1% | +36.8% | +4.6% | +32.5% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.1% | 54.4% | 53.6% | 50.4% | 53.5% | 54.8% | 55.6% | 56.3% | 58.3% | 58.4% | 59.0% | 57.3% | 59.7% | 60.2% | 62.3% | 60.6% | 64.2% | 62.9% | 64.2% | 63.1% | 61.9% |
| — | -0.8% | -3.5% | -10.5% | -8.3% | -6.2% | -5.8% | -1.7% | -2.3% | -2.9% | -5.3% | -5.5% | -6.9% | -4.3% | -3.0% | -3.9% | +3.6% | -1.7% | +5.7% | -0.9% | -11.2% | |
| Operating Margin | 20.7% | 20.7% | 18.2% | 15.6% | 22.3% | 20.5% | 21.5% | 18.6% | 24.7% | 24.0% | 25.5% | 19.5% | 15.3% | 24.2% | 25.6% | 19.5% | 27.3% | 29.5% | 34.4% | 26.1% | 30.8% |
| — | +1.4% | -15.2% | -16.1% | -9.4% | -14.9% | -15.8% | -4.8% | +61.4% | -0.7% | -0.4% | -0.0% | -44.0% | -18.1% | -25.5% | -25.1% | -11.3% | -12.0% | +11.2% | -21.1% | -37.8% | |
| Net Margin | 3.0% | 6.9% | 10.0% | -13.6% | 10.0% | 9.1% | 5.8% | 6.8% | 22.7% | 12.1% | 12.4% | 34.2% | 3.8% | 15.0% | 11.5% | 7.3% | 14.8% | 14.8% | 22.2% | 12.6% | 20.2% |
| — | -23.8% | +73.9% | -298.7% | -56.0% | -25.0% | -53.6% | -80.0% | +494.3% | -19.4% | +7.7% | +369.8% | -74.1% | +1.9% | -48.2% | -42.3% | -26.8% | -44.1% | -16.2% | -44.8% | -48.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 30.6% | 11.3% | 17.6% | -24.7% | 19.5% | 22.7% | 17.2% | 22.6% | 112.7% | 203.1% | 418.8% | — | — | — | — | — | — | — | — | — | — |
| — | -50.3% | +2.8% | -209.5% | -82.7% | -88.8% | -95.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | 1.4% | 0.8% | 1.1% | -1.6% | 1.2% | 1.1% | 0.7% | 0.8% | 2.9% | 1.6% | 1.7% | 4.7% | 0.5% | 2.2% | 1.6% | 1.0% | 2.2% | 2.2% | 3.3% | 1.8% | 2.9% |
| — | -24.1% | +70.4% | -284.0% | -59.0% | -32.9% | -60.5% | -82.2% | +446.5% | -27.1% | +3.0% | +368.8% | -75.5% | +0.9% | -50.2% | -45.0% | -25.7% | -46.9% | -19.0% | -49.6% | — | |
| ROIC | 10.8% | 2.9% | 2.3% | 2.0% | 3.0% | 2.7% | 2.7% | 2.6% | 3.5% | 3.6% | 3.8% | 3.0% | 2.2% | 3.8% | 3.9% | 3.0% | 4.4% | 4.9% | 5.7% | 4.5% | 5.3% |
| — | +6.2% | -16.0% | -23.8% | -15.9% | -23.5% | -27.8% | -13.3% | +57.2% | -6.4% | -3.4% | -0.4% | -48.8% | -22.3% | -30.6% | -33.3% | -17.3% | -21.5% | -5.9% | -38.7% | -41.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 11.70 | 8.50 | 9.49 | 11.70 | 9.74 | 12.14 | 16.52 | 19.14 | 17.75 | 60.11 | 181.54 | — | — | — | — | — | — | — | — | — | — |
| — | -29.9% | -42.6% | -38.9% | -45.1% | -79.8% | -90.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | 5.37 | 21.22 | 24.34 | 26.91 | 19.75 | 21.44 | 21.07 | 24.29 | 19.06 | 19.15 | 18.19 | 24.01 | 29.54 | 19.53 | 19.31 | 26.64 | 18.28 | 17.17 | 15.36 | 19.51 | 17.62 |
| — | -1.0% | +15.5% | +10.8% | +3.6% | +11.9% | +15.8% | +1.2% | -35.5% | -1.9% | -5.8% | -9.9% | +61.6% | +13.8% | +25.7% | +36.6% | +3.7% | +4.4% | +409.4% | +35644.6% | — | |
| Current Ratio | 1.82 | 1.95 | 1.97 | 1.82 | 1.75 | 1.65 | 1.67 | 1.60 | 1.70 | 1.64 | 1.65 | 1.54 | 1.63 | 1.66 | 1.61 | 1.56 | 1.54 | 1.58 | 1.61 | 1.45 | 1.38 |
| — | +18.3% | +18.0% | +13.8% | +2.9% | +0.9% | +1.4% | +3.5% | +4.8% | -1.3% | +2.3% | -1.3% | +5.4% | +5.3% | -0.1% | +8.1% | +11.5% | +19.8% | +55.7% | +8.5% | — | |
| Quick Ratio | 1.23 | 1.44 | 1.42 | 1.23 | 1.20 | 1.13 | 1.15 | 1.11 | 1.21 | 1.17 | 1.15 | 1.09 | 1.15 | 1.16 | 1.13 | 1.17 | 1.17 | 1.18 | 1.20 | 1.10 | 1.09 |
| — | +27.0% | +23.7% | +10.7% | -0.8% | -3.2% | -0.2% | +1.8% | +5.2% | +1.2% | +1.7% | -6.1% | -1.3% | -1.9% | -5.7% | +6.4% | +6.9% | +16.8% | +68.4% | +10.3% | — | |
| Interest Coverage | 1.84 | 2.69 | 2.92 | -0.22 | 2.90 | 2.73 | 1.81 | 2.01 | 2.64 | 2.79 | 2.80 | 1.81 | 1.60 | 2.92 | 2.78 | 2.44 | 3.61 | 3.93 | 5.56 | 4.27 | 4.97 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OGN stock.
Organon & Co.'s current P/E is 19.1x. The average P/E over the last 3 quarters is 5.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Organon & Co.'s current operating margin is 20.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Organon & Co.'s business trajectory between earnings reports.